2023 Pathology Review: Head and Neck, Breast and Dermatopathology for the General Pathologist - A CME Teaching Activity

This CME teaching activity is designed to provide a practical review of head and neck, breast and dermatopathology. Faculty will discuss basic to advanced techniques, pitfalls and pearls to pathologic diagnosis. Interactive case reviews emphasizing the material presented will round out the program.

This CME activity is primarily intended and designed to educate pathologists.

Educational Symposia

Physicians: Educational Symposia is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Educational Symposia designates this enduring material for a maximum of 16.75 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All activity participants are required to complete the credit application in order to be awarded credit. Course participants will also have the opportunity to critically evaluate the program as it relates to practice relevance and educational objectives.

AMA PRA Category 1 Credit(s)^TM for these programs may be claimed until April 30, 2026.

This program is planned and organized by Educational Symposia, a leader in accredited continuing education since 1975.

This activity was planned and produced in accordance with the ACCME Essential Areas and Elements.

At the completion of this CME teaching activity, you should be able to:

• Achieve a better understanding of sinonasal tract pathology.
• Review salivary gland pathology.
• Identify and better understand thyroid gland pathology.
• Review Head and Neck SCC.
• Review cutaneous anatomy and embryology to better understand the origin of tumors.
• Achieve a deeper understanding of basal cell and squamous cell carcinomas.
• Review mycosis fungoides.
• Discuss diagnosis and management of Intermediate grade melanocytic tumors.
• Identify and classify Nevi and problematic melanocytic neoplasms.
• Review clinicopathologic correlation in inflammatory skin disease.
• Understand the implications of traditional and newer prognostic and predictive factors in breast cancer.
• Discuss current issues and controversies regarding ER and HER2 testing in breast cancer.
• Better understand benign atypical proliferative lesions in breast disease.
• Understand immunohistochemistry as part of the diagnostic evaluation of breast lesions.
• Participate in interactive reviews of challenging breast pathology cases.

No special educational preparation is required for this CME activity.